Search Results - "Micaily, Ida"
-
1
Metabolic Pathways and Targets in Chondrosarcoma
Published in Frontiers in oncology (06-12-2021)“…Chondrosarcomas are the second most common primary bone malignancy. Chondrosarcomas are characterized by the production of cartilaginous matrix and are…”
Get full text
Journal Article -
2
VTE and anticoagulation in menstruating women
Published in Thrombosis update (01-12-2021)“…Women of childbearing potential have a high prevalence of venous thromboembolism (VTE) due to high estrogen states, such as pregnancy and the use of…”
Get full text
Journal Article -
3
Posterior reversible encephalopathy syndrome (PRES) after bevacizumab therapy for metastatic colorectal cancer
Published in Journal of community hospital internal medicine perspectives (01-05-2018)“…Posterior reversible encephalopathy syndrome (PRES) is an increasingly recognizable neuro-clinical syndrome. Clinical and neurological manifestations of PRES…”
Get full text
Journal Article -
4
A deadly prescription: combination of methotrexate and trimethoprim-sulfamethoxazole
Published in Journal of community hospital internal medicine perspectives (01-05-2018)“…Methotrexate (MTX) is a chemotherapeutic synthetic(s) phase cell cycle inhibitor, and its role has evolved as an immunological agent in autoimmune diseases…”
Get full text
Journal Article -
5
-
6
PLWH and lung cancer: A single cancer center experience in Philadelphia, PA
Published in Journal of clinical oncology (01-06-2024)“…e20502 Background: Lung cancer has been identified as the leading cause of cancer-related deaths in people living with HIV (PLWH), and disproportionately…”
Get full text
Journal Article -
7
A real-world comparison of efficacy and toxicity of FOLFIRINOX and gemcitabine to nab-paclitaxel in treatment of advanced stage pancreatic cancer
Published in Journal of clinical oncology (20-05-2020)“…Abstract only e16728 Background: Pancreatic adenocarcinoma is a dreaded malignancy accounting for 7% of all cancer related deaths in the United States. The two…”
Get full text
Journal Article -
8
484: AUTOIMMUNE DISEASE AND MULTIORGAN FAILURE: A CASE OF CATASTROPHIC ANTIPHOSPHOLIPID ANTIBODY SYNDROME
Published in Critical care medicine (01-01-2019)Get full text
Journal Article -
9
A Rare Case of Hemophagocytic Lymphohistiocytosis of Unknown Etiology
Published in Blood (08-12-2017)“…Hemophagocytic lymphohistiocytosis (HLH) is an uncommon cytokine storm syndrome marked which can cause high mortality. In adults, acquired HLH usually has an…”
Get full text
Journal Article -
10
The Appropriateness of Fresh Frozen Plasma (FFP) Administration in Three Community Teaching Hospitals
Published in Blood (13-11-2019)“…Objective: Although Fresh Frozen Plasma (FFP) is indicated in critically ill patients, there are growing concerns about it's cost effectiveness and adverse…”
Get full text
Journal Article -
11
Evaluating the clinical impact of primary tumor location in pancreatic adenocarcinoma
Published in Journal of clinical oncology (20-01-2021)“…Abstract only 428 Background: Pancreatic adenocarcinoma is the fourth most common cause of cancer-related death in the US. The location of the primary lesion…”
Get full text
Journal Article -
12
Change in body mass index in breast cancer patients in the first two years from diagnosis
Published in Journal of clinical oncology (20-05-2020)“…Abstract only e19020 Background: The rate of obesity in adults is 34% in the city of Philadelphia, with rates being highest among non-Hispanic blacks and…”
Get full text
Journal Article -
13
Comprehensive molecular characterization of thymic epithelial tumors
Published in Journal of clinical oncology (01-06-2024)“…8113 Background: Thymic epithelial tumors (TETs), which include thymomas (T) and thymic carcinomas (TC), are rare, yet they are the most common neoplasms in…”
Get full text
Journal Article -
14
TOMM20 as a Potential Prognostic Biomarker in Chordoma: Results From a High-Volume, Single-Center Study
Published in American journal of clinical pathology (02-05-2023)“…Abstract Objectives As few large studies identify correlative biomarkers in chordoma, our objective was to use our large, single-center chordoma tumor bank to…”
Get full text
Journal Article -
15
An update on angiogenesis targeting in head and neck squamous cell carcinoma
Published in Cancers of the head & neck (06-04-2020)“…Angiogenesis is an integral aspect of the growth and proliferation of solid tumors, including head and neck squamous cell carcinoma (HNSCC), and has potential…”
Get full text
Journal Article -
16
Association of pancreatic adenocarcinoma location (head/body/tail) with DDR mutation status and response to platinum-based therapy
Published in Journal of clinical oncology (01-02-2022)“…Abstract only 612 Background: Pancreatic adenocarcinoma is an aggressive disease with poor clinical prognosis that can originate from either the head (H) or…”
Get full text
Journal Article -
17
Treatment of vitamin D deficiency in transfusion‐dependent thalassemia
Published in American journal of hematology (01-10-2011)Get full text
Journal Article -
18
Comprehensive review of acute oesophageal necrosis
Published in BMJ case reports (01-02-2019)“…Acute oesophageal necrosis, also known as ‘black oesophagus’, is a rare condition characterised by the black discolouration of the oesophageal mucosa on…”
Get full text
Journal Article -
19
Image-guided high-dose-rate intracavitary brachytherapy in the treatment of medically inoperable early-stage endometrioid type endometrial adenocarcinoma
Published in Brachytherapy (01-11-2017)“…The purpose of this case series is to describe the treatment and outcomes of a cohort of patients with inoperable early-stage endometrioid endometrial cancer…”
Get full text
Journal Article -
20
Abstract CT068: Interim results of the ongoing phase 1-2 clinical trial of KVA12123, an engineered IgG1 targeting VISTA, as monotherapy and in combination with pembrolizumab in patients with advanced solid tumors
Published in Cancer research (Chicago, Ill.) (05-04-2024)“…Abstract V-domain Ig Suppressor of T-cell Activation (VISTA), a promising immuno-oncology target, is primarily expressed by immunosuppressive myeloid cells…”
Get full text
Journal Article